Trulieve Cannabis Corp. (OTCMKTS:TCNNF – Get Free Report) shares fell 4.7% on Monday . The company traded as low as $11.03 and last traded at $11.29. 599,175 shares changed hands during trading, a decline of 0% from the average session volume of 601,879 shares. The stock had previously closed at $11.85.
Analysts Set New Price Targets
Separately, Needham & Company LLC raised their price target on Trulieve Cannabis from $6.50 to $13.50 and gave the stock a “buy” rating in a research note on Friday, March 1st.
Read Our Latest Stock Report on TCNNF
Trulieve Cannabis Trading Down 4.7 % The company has a fifty day moving average price of $9.50 and a two-hundred day moving average price of $6.90. About Trulieve Cannabis
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.
Featured Articles
Receive
